Christina K Isacson Net Worth & Insider Trades

Christina K Isacson - Chief Business Officer, Magenta Therapeutics, Inc

As of February 12, 2020

What is Christina K Isacson's Net Worth?

The current estimated net worth of Magenta Therapeutics, Inc's Chief Business Officer, Christina K Isacson, is estimated to be about $379.48K . Christina K Isacson owns about 83,786 units of Magenta Therapeutics, Inc common stock. In the last 2 years at Magenta Therapeutics, Inc, Christina K Isacson has sold an estimated value of $316.64K worth.

What is Christina K Isacson's Past Insider Trading?

Christina K Isacson's largest sale order was 9,867 units , worth over $158.17K on December 26, 2019. In total, Christina K Isacson has made about 6 transactions over 2 years of their time at Magenta Therapeutics, Inc. Christina K Isacson usually trades in June, February and December, with the busiest year in 2019. The most recent transaction was a sale order of 4,463 units , worth over $71.45K on December 26, 2019.

Christina K Isacson

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

What is Christina K Isacson's' Mailing Address?

  • Mailing address is C/o Magenta Therapeutics 50 Hampshire Street Cambridge MA 02139 MA

Magenta Therapeutics, Inc Executive Compensation

Name
Year
Salary
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Jason Gardner, D.Phil. 2020 $530,000 - $2,309,592 $262,000 $1,256 $3,102,848
Jason Gardner, D.Phil. 2019 $515,000 - $903,764 $231,750 $487 $1,651,001
John C. Davis, Jr., M.D. 2020 $445,376 - $1,153,528 $162,000 $1,256 $1,762,160
John C. Davis, Jr., M.D. 2019 $417,000 - $345,899 $150,120 $502 $913,521
Stephen F. Mahoney 2020 $70,000 - $1,888,655 - $475 $1,959,130
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1690585/000119312521123656/d32109ddef14a.htm

What are Magenta Therapeutics, Inc's Past Insider Trades?

Magenta Therapeutics, Inc's most recent insider trade came on February 9, 2023 by Third Rock Ventures Iv Lp, Third Rock Ventures GP Iv Lp and Trv GP Iv Llc who sold 3,700,000 units worth $3.06M . In the last 5 years, insiders at Magenta Therapeutics, Inc have sold an estimated value of $7.27M and bought an estimated value of $10.45M worth of shares. Insider trading is most common in June, with the busiest year in 2022. The most active traders at the company are Jason Gardner, See Remarks,  Michael P Cooke, Chief Scientific Officer,  and Kristen Stants, Chief People Officer .

Magenta Therapeutics, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...